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Extracorporeal membrane oxygenation (ECMO) in blood-outside devices equipped with
hydrophobic membranes has become routine treatment of respiratory or cardiac failure.
In spite of membrane hydrophobicity, significant amounts of plasma water may form in
the gas compartment during treatment, an event termed plasma water breakthrough.
When this occurs, plasma water occludes some gas pathways and ultimately cripples
the oxygenator gas exchange capacity requiring its substitution. This causes patient
hemodilution and increases the activation of the patient’s immune system. On these
grounds, the resistance to plasma water breakthrough is regarded as an important
feature of ECMO devices. Many possible events may explain the occurrence of plasma
breakthrough. In spite of this, the resistance to plasma breakthrough of ECMO devices
is commercially characterized only with respect to the membrane maximal pore size,
evaluated by the bubble pressure method or by SEM analysis of membrane surfaces.
The discrepancy between the complexity of the events causing plasma breakthrough in
ECMO devices (hence determining their resistance to plasma breakthrough), and that
claimed commercially has caused legal suits on the occasion of the purchase of large
stocks of ECMO devices by large hospitals or regional institutions. The main aim of
this study was to identify some factors that contribute to determining the resistance to
plasma breakthrough of ECMO devices, as a means to minimize litigations triggered by
an improper definition of the requirements of a clinically efficient ECMOdevice. The results
obtained show that: membrane resistance to breakthrough should be related to the size
of the pores inside the membrane wall rather than at its surface; membranes with similar
nominal maximal pore size may exhibit pores with significantly different size distribution;
membrane pore size distribution rather than themaximal pore size determinesmembrane
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resistance to breakthrough; the presence of surfactants in the patient’s blood (e.g., lipids,
alcohol, etc.) may significantly modify the intrinsic membrane resistance to breakthrough,
more so the higher the surfactant concentration. We conclude that the requirements of
ECMO devices in terms of resistance to plasma breakthrough ought to account for all
these factors and not rely only on membrane maximal pore size.
Keywords: ECMO, membrane, plasma breakthrough, pore size, surfactants
INTRODUCTION
Extracorporeal membrane oxygenation (ECMO) has become
routine treatment of respiratory or cardiac failure patients, and
has been proven effective for both adults and newborns (Bartlett
et al., 2000; Betit, 2018). ECMO devices were first introduced
in the ‘70s as an alternative to mechanical respirators and
bubble oxygenators to substitute for the gas exchange function
of the natural lung in the treatment of Acute Respiratory
Failure (ARF) and in open heart surgery (Presenti et al., 1988).
Since then, the use of membrane devices for blood oxygenation
and CO2 removal (ECCO2R) in extra-corporeal circulation
has reduced the mortality associated with ARF and the post-
operative complications caused by mechanical respirators and
bubble oxygenators. Regardless of the connection scheme to
the blood circulation of the host, in ECMO and ECCO2R the
membrane gas exchanger is required to operate without loss
of gas transfer capacity from about 8 h up to 14 days, at least
(Gaylor, 1988; Montoya et al., 1992; Shimono et al., 1996, 1997).
Initially, ECMOsweremainly using homogeneous, dense silicone
membranes as barriers between the blood and the gases. The use
of microporous hollow fibers made of hydrophobic polyolefins
(e.g., polypropylene, PP, and polyethylene) has permitted to
enhance the effectiveness of gas exchange of ECMO devices. In
fact, the polymer hydrophobicity prevents plasma water from
entering the membrane pores and gases may freely and quickly
diffuse through the stagnant gas trapped in the pores. As a result,
oxygen transfer to blood through microporous membranes is
limited only by the mass transport resistance of the stagnant layer
of plasma at the blood-membrane interface, membrane resistance
to transport being negligible (Gaylor, 1988). This has prompted
the development of new ECMO designs where blood flows in
patterns that promote mixing and minimize the resistance to
oxygen transport of the stagnant blood layer adhering on the
membrane. The Extra-Luminal Flow (ELF) concept is one of
such new designs in which the blood flows outside hollow fiber
membranes arranged in cross-wound mats whilst a gas, rich in
oxygen and poor in carbon dioxide, flows inside the membrane
lumen counter–/ or cross-currently (Catapano et al., 1992).
Its efficiency significantly reduces the membrane surface area
required to bring the patient blood to a given oxygen saturation
level and has made it the reference design for clinical ECMO
devices (Catapano et al., 1992, 2001).
In spite of the membrane hydrophobicity, the presence of
significant amounts of blood plasma water in the membrane
lumina during treatment has been occasionally reported in
short-term ECMO and is a known complication of prolonged
ECMO (Meyns et al., 2005). Such phenomenon is often
referred to as “membrane wetting,” “plasma leakage,” or “plasma
breakthrough,” the last one in analogy to solute outbreak
in devices for liquid chromatography. When this occurs,
blood plasma occludes some of the gas pathways, increases
the resistance to gas transport in the gas compartment, and
ultimately decreases or cripples the oxygenator gas exchange
capacity. This requires substitution of the oxygenator, which
causes patient hemodilution and increases the activation of the
patient’s immune system for the contact with additional foreign
surfaces (Mottaghy and Hahn, 1981; Montoya et al., 1992).
On these grounds, the use of ECMO devices equipped with
microporous, hydrophobic membranes is not recommended
for long-term respiratory support and resistance to plasma
breakthrough is often regarded as an important feature of
ECMO devices.
Many possible causes have been proposed to explain the
occurrence of plasma breakthrough (Mottaghy and Hahn, 1981;
Lund et al., 1998; Eash et al., 2004; Gill et al., 2015), from
the presence of defects (e.g., pinholes) in the membrane wall,
to water vapor condensation (Mottaghy et al., 1989) in the
gas compartment, to excessively high transmembrane pressures
(Tamari et al., 1991), to the adsorption of blood-borne surfactants
on membrane pore wall which change its hydrophobicity
(Kida et al., 2018), to quote but a few. In spite of this,
the resistance to plasma breakthrough of ECMO membranes
is commercially characterized with respect to one parameter
only, the maximal pore size, which is generally evaluated with
the bubble pressure method (Hernández et al., 1996), and
occasionally estimated by scanning electron microscopy (SEM)
analysis of the membrane surfaces.
The discrepancy between the complexity of the events causing
plasma breakthrough in ECMO devices (hence determining
their resistance to plasma breakthrough), and that claimed
commercially has spurred controversy, and caused litigations
and legal suits on the occasion of the purchase of large stocks
of ECMO devices by large hospitals or regional institutions
with significant costs for society at large. In this paper, we
provide evidence of some factors that contribute to determining
the plasma resistance of ECMO devices, as a means to
minimize litigations triggered by an improper definition of
the requirements that a resistant ECMO device has to meet.
In particular, we provide evidence of the fact that membrane
resistance to breakthrough should be related to the size of the
pores inside the membrane wall rather than at its surface, that
membranes with a nominal maximal pore size indeed exhibit
pores with a size distribution that may significantly differ as an
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effect of small variations of the production parameters, and so its
resistance to breakthrough, that the presence of surfactants in the
patient’s blood (e.g., lipids, alcohol, etc.) may significantly modify
the intrinsic membrane resistance to breakthrough, more so the
higher the surfactant concentration.
MATERIALS AND METHODS
Membranes and Membrane Modules
In this study, microporous polypropylene membranes were
used throughout that were prepared in small amounts by
thermal induced phase separation (TIPS) with a laboratory
spinning apparatus. They were kindly provided for this study
by Membrana GmbH (Wuppertal, Germany) (now 3MTM
MembranaTM). The reference composition of the polymer dope
and the extraction liquid, and the operating conditions were
those used for the preparation of commercial microporous
polypropylene membranes with 0.1µm nominal maximal pore
size, 40% porosity, 280µm inner diameter, 50µmwall thickness.
Membranes with different pore structures were prepared by
slightly changing some of the preparation parameters (e.g.,
polymer content, solvent, and extracting liquid composition) to
simulate fluctuations potentially occurring during production
in case of faulty quality control. Hereinafter, these membranes
shall be referred to as Type I to VI. The maximal pore size of
the investigated membranes was characterized by bubble point
measurements and was consistently lower than 0.13µm. To
test their resistance to water breakthrough in the presence of
surfactants, membranes of a given batch were assembled in
laboratory-scale modules of about 0.167 m2 membrane surface
area in a shell-and-tube configuration, their ends were potted
with glue, and the membrane length protruding out of the
cylindrical housing was cut with a sharp blade. This study was
intended to guide membrane makers to develop membranes
resistant to plasma breakthrough. For this reason, possible
correlations between membrane pore structure and resistance
to breakthrough were sought only for those membranes that
exhibited a better resistance to breakthrough in preliminary
experiments (i.e., Type I-IV). In such a case, possible time
changes of membrane properties during the spinning procedure
were minimized by using for testing only membranes spun in
very short time intervals.
Membrane Pore Characterization
Pore morphology and size of somemembranes was characterized
both at the outer membrane surfaces and inside the membrane
wall by scanning electron microscopy (SEM) and by liquid
porosimetry, as described below.
Scanning Electron Microscopy Analysis
Scanning electron micrographs were taken from different areas
of membrane samples with a Stereoscan S-440 (Leica-Cambridge
Leo, Wetzlar, Germany) SEM operated at accelerating voltages
of 10 and 20 kV. Membrane samples were prepared for SEM by
drying, breakage in liquid nitrogen, fixation to a SEM spin stub
with a conductive adhesive, and sputter coated with a 20 nm layer
of gold. Micrographs were taken of both membrane outer and
inner surfaces and of membrane cross-sections.
Liquid Porosimetry Analysis
The distribution of pore size in the membrane wall and the
relative hydraulic permeability (i.e., the fractional permeating
flow rate) associated with pores in a given size range was
characterized by liquid-liquid displacement porosimetry (LLDP)
with a proprietary automated porosimeter (Calvo et al., 2004).
Measurements were performed with an isobutanol–water pair,
using isobutanol for wetting and water to displace it at increasing
operating pressures, at 20◦C. Membrane samples from any given
batch were immersed in the LLDP wetting phase under vacuum
to ensure complete membrane wetting. The pore radius, rp,
corresponding to the measured volumetric flow rate of displaced
water at any given operating pressure was estimated from
the current pressure value, and for cylindrical straight pores,





Equation (1) is the force balance inside a cylindrical straight
through-pore in a membrane, and relates the pressure, 1P,
at which a liquid breaks through the pore of size rp, for a
surface tension of the liquid–air- membrane interface γ , and
a membrane contact angle with water θ. In the analysis of the
LLDP curves, γ was taken as the surface tension of the water–
isobutanol-membrane interface, and θ = 0 for complete wetting.
Effect of Surfactants on Water
Breakthrough
The experimental apparatus used to test membrane resistance
to water breakthrough in the presence of surfactants is
schematically shown in Figure 1. Before any experiment, a
module was rinsed by flowing 1 L of 0.9% sodium cloride saline
solution in the module shell in single-pass mode at 240 mL/min,
at room temperature. Then, 200ml of saline solution, previously
warmed to 37◦C, was recirculated in closed loop trough the
module at the same flow rate for 10min. While rinsing the
module, gaseous nitrogen warmed at 38◦C was kept flowing at
3 L/h in the membrane lumen counter-currently with respect
to saline.
Membrane resistance to water breakthrough was
characterized with respect to saline solutions containing egg yolk
L-α phosphatidylcholine (Type XV-E, Sigma, Milan, Italy) at
concentrations ranging from 0.37 to 12 g/L. Resistance to water
breakthrough of membranes Type I to IV was characterized
with solutions containing 3.1 g/L phosphatidylcholine. In
the experiments, 200mL of test solution kept at 37◦C was
recirculated in closed loop at a flow rate of 240 mL/min
between module shell and the reservoir hosting the solution,
while the level of the test solution in the reservoir was
continuously controlled with a level-controller to avoid the
solution concentration by evaporation. Little liquid losses were
replenished with saline. Gaseous nitrogen, warmed at 38◦C, was
kept flowing counter-currently in the membrane lumen at 3
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FIGURE 1 | Scheme of the experimental apparatus used for testing the resistance to water breakthrough of modules equipped with the investigated membranes: FC,
fraction collector; FR, flow controller of gas stream; IB, ice bucket; LR, level controller; P, pump; PC, personal computer; PT, pressure transducer; RS, reservoir with
solution; TH, thermostat for gas heating; WB, thermostated water bath.
L/h. The pressure at the module sections at which the test liquid
solution would enter or leave the module was continuously
monitored, so was the inlet gas pressure. Water vapor in the gas
stream leaving the module was continuously condensed in an
ice-cooled tube and the condensate was continuously sent with
a pump to a fraction collector for further condensate analysis.
The water flow rate leaving the module through the gas side, Qw,
was estimated in terms of the mass of condensate collected in
1 h. A patent membrane module was used for each experiment.
Experiments to assess the effect of phosphatidylcholine
concentration on the water breakthrough time were performed
on four modules equipped with membranes Type V or VI at
each concentration. When one or a few membranes in a module
proved faulty (e.g., exhibiting pinholes) the experiment was
discarded. The number of successful experiments modules tested
under any given condition was not deemed high enough to
perform a statistical analysis.
Figure 2 shows a typical water breakthrough curve expressed
in terms of time variation of Qw. The time to water breakthrough,
BT, for any membrane investigated in this study was estimated
from experimental Qw vs. t curves as the time coordinate of the
intercept between the linear parts of each Qw vs. t curve at the
beginning and toward the end of the experiment. Phospholipid
penetration into the membrane pores and adsorption on
their surface was investigated by assessing the presence of
phosphatidylcholine by SEM elemental analysis of membrane
cross-sections at the end of the experiments.
RESULTS
Membrane Pore Characterization
SEM analysis of the investigated membranes typically showed
that pore density and size was rather different at the two
membrane surfaces and along the membrane thickness. Pores
on the surfaces were bordered with stretches of polymer, of
varying surface area, and were generally elongated. As shown
in Figures 3A,B, pore density was lower at the outer membrane
surface, that contacting the blood in ELF ECMO device, than
the inner membrane surface. Figure 3C shows that, inside
the membrane wall, pores appeared as rather spherical voids
(different than the finger-like voids typical of hemodialysis
membranes) and their density decreased from the outer to the
inner membrane surface. Only a fraction of pores appeared
to be through pores, definitely no cylindrical and straight
pore was to be seen, opposite to that often assumed in many
theoretical models.
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FIGURE 2 | Typical time variation of the water flow rate leaving the module
through the gas side of modules equipped with membranes Type I.
Experiment performed as described in Materials and Methods with solutions
containing 3.1 g/L phosphatidylcholine.
The analysis based on liquid-liquid displacement porosimetry
permitted to characterize the effective transport features of the
pores inside the wall of the investigated membranes. As shown in
Figure 4, small variations of the preparation parameters yielded
membranes with significantly different pore size distributions.
Albeit to varying extent, all membranes exhibited pores greater
than the nominal maximal pore, and only a few exhibited pores
smaller than that. The pore size distribution was also broader
than expected, for some of them. Figure 4C shows that only
the Type III membranes exhibited a very narrow pore size
distribution with mean pore size close to the nominal maximal
pore size.
Effect of Surfactants on Water
Breakthrough
Figure 2 shows a typical water breakthrough curve in terms
of time variation of the mass flow rate of water leaving the
module through the gas side. At the beginning of the test,
water is transported across the membrane wall as a vapor at
a rather constant and very low flow rate, generally well below
10−3 g/min. After water breakthrough occurs, water is mainly
transported across the membrane wall as a liquid at a rate
that continuously increases in time. Water breakthrough was
evidenced by the corresponding pressure increase (up to about
4 times the initial pressure) of the gas stream entering the
membrane module (hence membrane lumina). The pattern of
time increase of the water flow rate after breakthrough varied
with the membrane type and its pore size distribution. Transition
from the former to the latter regime occurred in a time interval
FIGURE 3 | SEM images of samples of membranes Type I: (A) inner surface;
(B) outer surface; (C) cross-section of membrane wall.
that varied with the membrane type and its pore size distribution.
In some cases, elemental analysis evidenced the presence of
phosphatidylcholine adsorbed on the pore surface inside the
membrane wall caused by the flow of the liquid solution across
the pores after breakthrough occurred.
In the presence of phosphatidylcholine concentrations slightly
higher than in plasma, all investigated membranes exhibited
water breakthrough times well in excess of that required for
their use in ECMOs for open heart surgery. The experimental
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FIGURE 4 | Pore size distribution and fractional hydraulic permeability of various membranes: (A) Type I; (B) Type II; (C) Type III; (D) Type IV.
breakthrough times varied with the membrane pore size
distribution. Table 1 shows that the breakthrough times are
better correlated to the membrane mean pore size than the
maximal pore size, and significantly decreased with increasing
mean pore size. Figure 5 shows that the water breakthrough
time decreased exponentially when the membranes were
exposed to solutions containing increasing concentrations of
phosphatidylcholine. Figure 5 shows that the breakthrough time
was not significantly affected by the membrane properties
when membranes were exposed to high phosphatidylcholine
concentrations. Membrane properties significantly affected the
breakthrough time when membranes were exposed to lower
phosphatidylcholine concentrations, in the range of the values
typically found in human plasma.
DISCUSSION
The efficiency of microporous hydrophobic membranes in
transporting gases to/from the blood in ECMO is mainly due
to the fact that gases quickly diffuse across the column of
stagnant gas present in the membrane pores, while polymer
hydrophobicity prevents plasma water from crossing the
membrane. On purely theoretical grounds, the absence of a dense
barrier between the gas and the blood stream could lead to the
formation of micro-emboli in the blood that could expose ECMO
TABLE 1 | Breakthrough time, BT, of modules equipped with the investigated
membranes as a function of their mean, Rmean, minimal, Rmin, and maximal, Rmax,
pore size.
Membrane type Membrane features
Rmean [nm] Rmin [nm] Rmax [nm] BT [h]
I 257 66 1,070 30.7
II 404 90 873 25.0
III 240 181 369 >43.0
IV 560 213 873 15.6
Experiments performed as described in Materials and Methods with solutions containing
3.1 g/L phosphatidylcholine.
patients to serious hazards. As it can be estimated from Equation
(1), for polyolefin membranes with maximal pore size a tenth
of a micron large, microbubble formation may occur only when
the oxygenator is operated at high gas pressures (e.g., when gas
flow rate is increased to recover some gas exchange capacity
lost for plasma leakage) (Gill et al., 2015) or when pinholes are
present in the membrane wall (i.e., with faulty membranes). In
this study, micro-emboli formation was not investigated because
experiments with faulty membranes were discarded and gas flow
rate was not increased when plasma leakage occurred because the
study was not focused on the characterization of the oxygenator
gas exchange capacity.
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FIGURE 5 | Breakthrough time for different phosphatidylcholine
concentrations of modules equipped with different membranes: (1, - - -) Type
V; (, ____) Type VI. Other operating conditions as in Materials and Methods.
Equation (1) shows that pore size, but also the interfacial
surface tension, γ, and the membrane contact angle, θ,
contribute to determining the barrier properties of microporous
membranes. It should also be considered that synthetic
membranes prepared by phase inversion generally exhibit pores
the size of which may be broadly distributed, depending on
the actual membrane preparation procedure. In spite of this,
the barrier properties of microporous membranes for ECMO
are generally characterized only in terms of their maximal
pore size estimated by bubble point measurements (Tylkowski
and Tsibranska, 2015), or by SEM analysis of the membrane
surfaces, as is often the case in commercial advertisements.
Such an oversimplified characterization of the resistance to
plasma breakthrough of ECMO devices has often been used
in the definition of the requirements that effective and safe
ECMO devices have to meet to qualify for purchasing by large
hospitals or regional institutions. The discrepancy between the
many factors causing plasma breakthrough in ECMO devices
and the simplicity of that required commercially has often led
to legal disputes in a court of law. This study was designed
to evidence the limits of using only the membrane maximal
pore size to characterize the resistance to plasma breakthrough
of ECMO devices, and to bring experimental evidence of the
extent to which the whole membrane pore size distribution
and the conditions under which an ECMO device is operated
determine the occurrence of water breakthrough. In the clinics,
the occurrence of plasma breakthrough is signaled by a decrease
of the ECMO gas exchange capacity (e.g., Gill et al., 2015),
an effectiveness parameter strongly dependent on the actual
fluid dynamics of the ECMO device (Catapano et al., 2001).
It is worthwhile noting that the methods used for this study
permitted to characterize the occurrence of plasma breakthrough
independent of measurements of the gas exchange across the
membrane wall, hence of the actual ECMOmodule design.
The SEM analysis in Figure 3 clearly shows that pores at
the membrane surfaces do not fully characterize membrane
resistance to breakthrough. In fact, not all surface pores are
through-pores, nor does their geometry and size at themembrane
surface always resemble those inside the membrane wall. In
agreement with Hernández et al. (1998), it is the pores inside
the membrane wall that determine the membrane transport
properties, unless a selective layer (i.e., a skin) is present at
one of the membrane surfaces. Equation (1) permits to estimate
the pressure at which water breaks through a membrane that
features through-pores all of which are cylindrical, with uniform
size, and have the same radius, rp. In spite of the fact that the
maximal pore size of the investigated membranes was lower than
0.13µm, the LLDP analysis reported in Figure 4 showed that
they generally featured a relatively broad pore size distribution,
and exhibited a significant fraction of pores larger than their
maximal pore size. Extension of Equation (1) to membranes
featuring pores of varying size suggests that the membrane
resistance to breakthrough ought to reflect the actual membrane
pore size distribution.
To investigate whether this is indeed the case, the resistance
to water breakthrough of the investigated membranes was
assessed in terms of the time it would take for water to
break through the membranes when they are continuously
challenged with a solution containing a surfactant. This would
simulate that happening during an ECMO treatment. In fact,
the blood contains many surface-active species at relatively
high concentrations (e.g., proteins and lipoproteins), more so
under pathological conditions (e.g., in case of elevated serum
lipoproteins and/or hypercholesterolemia). Exogenous surface-
active speciesmay also be present in the patient’s blood for his/her
personal habits (e.g., alcohols), or because they are given to the
patient in large amounts to treat cardio-pulmonary diseases (e.g.,
lipophilic drugs). The presence of surfactants in the blood, or
the test solution, has two important consequences. Firstly, they
significantly decrease the blood surface tension with respect to
water (Montoya et al., 1992). Secondly, they may adsorb on the
hydrophobic polymer of which ECMOmicroporous membranes
are made and decrease their contact angle, θ (i.e., make them
more hydrophilic). In fact, such surface-active species are all
amphiphilic (i.e., they possess both hydrophilic and hydrophobic
character). When they come in contact with a hydrophobic
polymer, they adsorb on them via their apolar domains to an
extent depending on their blood concentration and affinity to the
polymer, and expose their polar domains toward water. As more
surfactant molecules adsorb on the polymer surface, they may
end up forming a hydrophilic layer on top of the hydrophobic
polymer. This decreases the polymer contact angle and permits
plasma water to leak through the pores (Ishihara et al., 1993;
Philp et al., 1994). In this study, a phospholipid was used as
surface-active species because phospholipids are ubiquitous in
the body. They are present in plasma at concentrations ranging
from 1.58 to 2.84 g/L. The phospholipid concentrations used for
this study were chosen to encompass their physiological range
and to simulate pathological conditions, too. Consistent with that
expected, Figure 2 and the presence of phospholipids adsorbed
on the membrane wall show that after water breakthrough occurs
water is mainly transported across the membrane wall as a
liquid at a rate that continuously increases in time as an effect
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of phospholipid adsorption which causes wetting of pores of
decreasing size.
Comparison of the water breakthrough times at phospholipid
concentrations close to the upper physiological value (Table 1)
and the pore size distributions (Figure 4) exhibited by the
investigatedmembranes shows that, indeed, the entiremembrane
pore size distribution strongly influences the membrane
resistance to breakthrough. Membranes with a significant
fraction of large pores (i.e., Type II and IV) exhibited a short time
to breakthrough (and a poor resistance to water breakthrough),
the former shorter than the latter for the distribution slanted
toward pores close to the micron in size. Membranes with a
narrow pore size distribution exhibited a much longer time to
breakthrough (and a better resistance to water breakthrough)
than those with a broad pore size distribution (i.e., Type III vs.
Type I), in spite of the rather close mean pore sizes (i.e., 240
vs. 257 nm, respectively). Interestingly, the breakthrough time
correlated better with the mean pore size than the maximal pore
size, possibly because the former accounts better for the entire
pore size distribution of the investigated membranes.
Figure 5 shows that the exposure to increasingly high
phospholipid concentrations, exponentially decreases the
membrane water breakthrough time and minimizes the effects
of the different membrane pore structures. This is possibly due
to the fact the overwhelming presence of surface-active species
in the test solution quickly decreases the membrane contact
angle of all pore surfaces, and makes all of them wettable about
at the same time irrespective of differences in size. This result
is consistent with the premature breakthrough of plasma water
across microporous membranes for ECMO reported in the
cardiac surgery of alcoholics (Tylkowski and Tsibranska, 2015).
It is worthwhile noting that at concentrations of surface-active
species in the test solution≤ 1 g/L the actual membrane structure
significantly affects the membrane breakthrough time, and may
make it increase by up to a factor two.
CONCLUSIONS
In this paper we provide experimental evidence that the
membrane maximal pore size only (estimated by the bubble
point method or by SEM analysis of membrane surface)
does not fully characterize the resistance to plasma water
breakthrough of ECMO devices equipped with hydrophobic
microporous membranes. Different phenomena may occur at
the same time and may act cooperatively to initiate or favor
plasma breakthrough. The experimental characterization shows
that membrane resistance to breakthrough is better related
to the size of pores inside the membrane wall rather than
at its surface; that membranes with similar nominal maximal
pore size may exhibit pores with significantly different size
distribution; that membrane pore size distribution rather than
the maximal pore size determines the membrane resistance to
water breakthrough; that the presence of endogenous (e.g., excess
lipoproteins or cholesterol) or exogenous (e.g., alcohol or drugs)
surface-active species in the patient’s blood may strongly modify
membrane hydrophobic character and its intrinsic resistance to
breakthrough, more so the higher the species concentration.
The results of this study suggest that litigations and legal
suits might be minimized, in the first place, by avoiding that
administrative offices issue calls for purchase in which improper
definitions, based only on their membrane maximal pore size, are
used of the requirements that clinically effective ECMO devices
have to meet to be capable of resisting plasma breakthrough
during prolonged treatments. In the second place, policies
should be put in place to let authorized laboratories only test
commercially available ECMO devices and membranes under
standardized operating conditions so as to define the conditions
of use under which commercially available ECMO devices deliver
reproducible gas exchange performance and are safe in all
possible clinical use (i.e., short–/ or long-term).
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